Evidence that physical activity (PA) modulates the association between the fat mass and obesity-associated gene (FTO) and BMI is emerging; however, information about dietary factors modulating this association is scarce. We investigated whether fat and carbohydrate intake modified the association of FTO gene variation with BMI in two populations, including participants in the Genetics of Lipid Lowering Drugs and Diet Network (GOLDN) study (n = 1069) and in the Boston Puerto Rican Health (BPRHS) study (n = 1094). We assessed energy, nutrient intake, and PA using validated questionnaires. Genetic variability at the FTO locus was characterized by polymorphisms rs9939609 (in the GOLDN) and rs1121980 (in the GOLDN and BPRHS).
Introduction
Minor alleles at the FTO locus (namely, SNP 15 rs9939609 and rs1121980, both in high linkage disequilibrium) have been associated with higher BMI and obesity risk in multiple populations (1) (2) (3) (4) (5) (6) (7) (8) . Hence, the FTO gene has now been considered as one of the most important in common forms of obesity (9, 10) . However, despite the overall consistency reported, there are a number of studies in which the FTO gene has not been associated with BMI or obesity (11) (12) (13) (14) (15) .
These inconsistencies may be the result of gene-environment interactions between the FTO gene and lifestyle variables as suggested by some reports. This indicates that the effects of FTO variants on BMI are not unavoidable but, rather, can be considerably modulated by environmental factors. Identifying those environmental interactions will be needed for establishing targeted preventive approaches in individuals with greater genetic susceptibility to obesity. PA has been the environmental factor that is most commonly reported as showing a significant interaction with the effects of variations (both of the SNP rs9939609 and the rs1121980) in the FTO (16) (17) (18) (19) (20) (21) . Accordingly, a lower level of PA would boost the effect of the variants associated with high BMI (called risk-alleles), whereas a higher level of PA would neutralize the genetic effects of the risk-alleles on BMI. However, not all studies reported support this interaction of the FTO polymorphism with PA (22) (23) (24) . Recently, another relevant interaction of an FTO genetic variant (rs9939609) with total fat and carbohydrate intake in determining BMI has been described in middle-aged individuals in Sweden (20) . In this population (20) , the greater BMI in individuals with the FTO riskallele was restricted to those who reported a high-fat diet, whereas the FTO risk-allele was not associated with a higher BMI among participants with lower fat intakes. An inverse interaction was observed with carbohydrate intake. Despite its relevance, the consolidation of this gene-diet interaction has not been pursued in other populations, thus the need to undertake replication studies on this interaction. Moreover, because only total dietary fat was investigated in that study, it is necessary to go deeper into which types of fatty acids are most implicated in that interaction. Based on the results of our previous work in which we found that SFA consistently interact with polymorphisms associated with obesity (25), our hypothesis was that SFA may play an important role in modulating the effects of the FTO polymorphisms. Some human studies (mainly carried out in children) have found that participants carrying the FTO risk-allele consume more total energy and fat than noncarriers (26, 27) . Our objectives, therefore, were to: 1) study the association between FTO variants, anthropometric variables, and energy and macronutrient intake in two independent, adult, U.S. populations that differed in demographic and lifestyle characteristics; 2) determine whether the previously reported interaction between total fat and carbohydrate intake as well as the interaction of PA with the FTO variants on BMI could be replicated; and 3) investigate whether SFA intake has a stronger interaction than total fat intake in these populations.
Participants and Methods
We studied 2163 participants from two independent U.S. populations (the GOLDN and BPRHS) that had been extensively characterized by our group in previous studies (28, 29) . The IRB of the institutions involved approved the study protocols and all participants provided written informed consent.
The GOLDN Study. About 1200 adult individuals of European ancestry were recruited from two National Heart, Lung and Blood Institute Family Heart Study field centers (Minneapolis, MN and Salt Lake City, UT) as previously reported (28) . We included 1069 participants (507 men and 562 women) for whom genetic (rs1121980 and rs9939609 FTO polymorphisms), anthropometric, dietary, PA, and other control variables were available. The protocol was approved by the IRB at the Universities of Alabama, Minnesota, Utah, and Tufts.
The BPRHS. The study comprised approximately 1200 Puerto Rican (Hispanics of Caribbean origin) participants aged 45-75 y in the greater Boston area (29) and was derived from the NIH-funded Centers on Population Health and Health Disparities. We included 1094 (315 men and 779 women) participants for whom genetic (rs1121980), anthropometric, dietary, PA, and other control variables were available. The protocol was approved by the IRB at Tufts University.
Anthropometric and PA determinations. Anthropometric variables, including height, weight, and waist circumference, were measured (28, 29) . BMI was calculated as weight (kg)/height (m 2 ). Participants with a BMI $30 kg/m 2 were considered obese. PA in the GOLDN was assessed by an interviewer-administered questionnaire containing questions on the number of h/d dedicated to different levels (heavy, slight, and sedentary) of activity as well as the average number of h/d without activity (29, 30) . Afterwards, a single score representing PA was calculated (25, 29) . In the BPRHS, a PA single score based on the Paffenbarger questionnaire of the Harvard Alumni Activity Survey (31) was also estimated. In both populations, a higher score indicates a greater amount of PA.
Dietary intake and other lifestyle variables. Diet was measured by validated questionnaires in each specific population (32) (33) (34) . In the GOLDN, we estimated dietary intake with the Diet History Questionnaire (32, 33) . In the BPRHS, a specifically validated questionnaire for this population was used (34) . All the included participants had valid dietary intake data from the FFQ (total daily energy within the range of 800-5500 kcal in men or 600-4500 kcal in women). The percentage of individuals outside the inclusion range was very low (3.6% in GOLDN and 4.2% in BPRHS).
Data on smoking and drinking were obtained as previously described (29, 30) .
Genetic analyses. DNA was isolated from blood (Qiagen). We performed FTO genotyping (rs1121980 and rs9939609 in the GOLDN and rs1121980 in the BPRHS) using Taqman assays with allele-specific probes on the ABIPrism 7900HT Sequence Detection System (Applied Biosystems). All genetic analyses were undertaken in the same laboratory. Quality control measures were applied. Genotype frequencies were consistent with Hardy-Weinberg equilibrium in both populations. . Enrollment of ;1040 participants would be necessary for our association study to have 80% power (a-level = 0.05) in each population. Therefore, post hoc power calculations showed that our study incorporating 1069 participants in the GOLDN and 1069 participants in the BPRHS had 81% power in each population to show significant associations with BMI at a = 0.05.
We also tested the statistical homogeneity by gender by checking the significance of the interaction term between the FTO SNP and gender, and men and women were analyzed together. Control for potential confounders was carried out by general mixed regression models. Models were adjusted for gender, age, tobacco smoking, and alcohol consumption. In the GOLDN, because this is a population in which some participants are related, additional adjustments for family relationships were undertaken as previously described (28) . In the BPRHS, further adjustment for admixture using the first component variable derived from the analysis of 100 ancestry informative markers was undertaken (35) .
To study gene-PA and gene-diet (macronutrient intake) interactions in determining BMI, we used multivariate linear regression models, including main effects and interaction terms. We included the same variables for each population. PA was considered both as categorical and continuous (log of the PA score). Dietary variables were also considered as categorical and as continuous. We adjusted analyses for gender, age, tobacco smoking, alcohol consumption, PA, and total energy intake. Considering the different options and controversies to categorize the variables of diet and the diverse ways to express nutrient intake (in g/d or percent of energy), we used two different approaches for the analyses. We used a model that uses dietary variables expressed in g/d and includes the adjustment for total energy intake (25) . This model is known as the standard multivariate energy-adjusted model (36) . In our analyses, macronutrient intakes were analyzed as categorical (based on the population means) as well as continuous. However, given that the previous study by Sonestedt et al. (20) found a significant interaction between the FTO SNP and total fat and carbohydrate intakes in determining BMI and obesity risk using dietary variables expressed in energy percentages (nutrient density model), we also fitted additional models expressing total fat and carbohydrate intakes as percent of energy and adjusting for energy intake (multivariate nutrient density) to determine if the results of Sonestedt et al. (20) could be replicated. For this second approach, we categorized macronutrient intakes in gender-specific tertiles to closely reproduce the same statistical model of the previous work (20) .
When the FTO-diet interaction was analyzed with dietary variables in continuous form, it was depicted by computing the predicted values for each individual from the adjusted regression model and plotting these values against fat intake by the FTO genotype. Stratified analyses by fat intake levels were also carried out. Logistic regression models, including main effects and interaction terms, were fitted to test the FTO associations and the gene-PA or gene-diet interactions for determining the OR of obesity. Multivariate adjustments were done as indicated.
Statistical analyses were conducted with SAS software (v.9.1; SAS Institute) and SPSS software (v.17.0). Standard regression diagnostic procedures were used to ensure the appropriateness of the fitted models. All reported probability tests were 2-sided. Differences were considered significant at P , 0.05. Because our study was conducted in two independent populations to discard random associations by chance, we did not proceed to adjust for multiple comparisons.
Results
Association of FTO variants with obesity measures and food intake. The two populations studied differed in demographic and lifestyle variables ( Table 1 ). In the GOLDN study, we did not observe significant associations between the FTO polymorphisms (rs1121980) ( Table 1 ) or rs9939609 (Supplemental Table 1 ) and anthropometric (weight, BMI, and waist circumference) or dietary variables (energy and macronutrient intakes). Both FTO polymorphisms were in high linkage disequilibrium (0.997; P , 0.001) and we obtained the same associations for both. After additional adjustment for gender, age, tobacco smoking, alcohol drinking, and family relationships, we did not find differences in the significance of the results. Like the GOLDN study, the minor allele at the rs1121980 SNP in the BPRHS (Table 1) was not associated with greater BMI or greater energy or fat intake in the codominant model. After adjustment for gender, age, tobacco smoking, alcohol drinking, and population admixture, the results did not change in significance. When the recessive model was tested, we did not find significant associations. The lack of associations with BMI in these populations was not due to a lack of statistical power but to the small magnitude of the effects associated with the risk-allele carriers (T allele for rs1121980 and the A allele for rs9939609).
Interactions between FTO variants and PA. In the GOLDN, we found a significant interaction between the rs1121980 and PA when three categories (based on the GOLDN population tertiles) were considered (Supplemental Fig. 1A) or when PA was analyzed as a continuous variable (Supplemental Fig. 2A) . We also observed significant interaction (P-interaction = 0.002) between the rs1121980 and PA tertiles on obesity (results not shown). In contrast, in the BPRHS, there were no significant interactions between PA and the rs1121980 SNP on BMI when three categories of PA (based on the BPRHS population tertiles) were considered (Supplemental Fig. 1B ) (P = 0.10) or when PA was analyzed as a continuous variable (Supplemental Fig. 2B ) (P = 0.07). Likewise, there were no significant interactions between PA and the FTO genotype on obesity (not shown). The FTO genotypes were rs9939609 (11+12: TT+TA; 22: AA) in the GOLDN study and rs1121980 (11+12: CC+CT; 22: TT) in the BPRHS study.
3 P-interaction between the corresponding FTO genotype and total fat intake or carbohydrate intake in the corresponding multivariate model (lineal or logistic adjusted for the corresponding covariables in determining BMI or obesity risk. 4 Models adjusted for gender, age, smoking, drinking, energy intake, and PA tertiles.
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P for the OR corresponding to the homozygotes for minor allele in comparison with the other genotypes in each strata. 8 Levels of intake were defined according to the corresponding population mean.
Interactions between FTO variants and dietary intake. A higher total fat intake was associated with higher BMI in homozygous participants for the minor allele of the FTO in both populations; these interactions reached a higher significance level in the GOLDN participants than in the BPRHS participants. Thus, in the GOLDN ( Table 2; Supplemental Table 2) , we found significant interactions between the FTO polymorphism and total fat intake on BMI whether total fat was expressed either as gender-specific tertiles of percent of energy (P = 0.017) or as two categories based on the mean intake in g/d (P = 0.027). In BPRHS participants (Table 2; Supplemental Table 2 ), we only found a significant interaction when total fat intake was expressed in g/d (P = 0.021). We did not observe a significant interaction with carbohydrate intake (Table 2; Supplemental  Table 3 ). Further, we investigated the specific effects of SFA intake on this interaction. In both the GOLDN and BPRHS, we obtained significant interactions both as categorical (Fig. 1) and continuous (Fig. 2) variables. In both populations, an SFA intake higher than the mean was associated with a higher mean of BMI in homozygous participants for the minor allele compared with the other genotypes (29.7 6 0.7 vs. 28.1 6 0.5 kg/m 2 ; P = 0.037 in GOLDN and 33.6. 6 0.8 vs. 31.2 6 0.4 kg/m 2 ; P = 0.006 in PBRHS). Accordingly, in the GOLDN, homozygous individuals for the minor allele did not have a higher risk of obesity than other genotypes when the SFA intake was low [below the population mean; OR = 0.79 (95% CI = 0.51-1.25)] (P = 0.32), whereas in the high-SFA intake stratum, the risk was higher and significant [OR = 2.10 (95% CI = 1.22-3.62)] (P = 0.008). In the BPRHS, these estimates were OR = 1.16 (95% CI = 0.74-1.82) (P = 0.51) for the low and OR = 1.75 (95% CI = 0.99-3.06) (P = 0.05) for the high-SFA intake stratum.
Finally, we examined the interaction effect of MUFA and PUFA intakes with the FTO polymorphism on BMI (Supplemental Table 4 ) and found consistent results in the GOLDN and BPRHS. PUFA intake did not interact with the FTO polymorphisms in determining BMI (P-interaction = 0.18 in GOLDN and P-interaction = 0.53 in BPRHS). However, we obtained significant interactions with MUFA in both the GOLDN and BPRHS participants (P-interaction = 0.012 and P-interaction = 0.021, respectively, for the categorical variables based on the population means). These results, mimicking that observed for FIGURE 1 BMI in participants in the GOLDN study (A) and the BPRHS (B) depending on the SFA intake (2 levels, based on the population mean: 27.6 g/d in GOLDN and 22.7 g/d in BPRHS) and the FTO polymorphisms (recessive model; rs9939609 in GOLDN and rs1121980 in BPRHS). Values are adjusted means 6 SEM. Models were adjusted for gender, age, tobacco smoking, alcohol drinking, PA, and total energy intake. P values for mean comparison in each saturated fat strata were also adjusted for covariates. *Different from CC+TT, P , 0.05. BPRHS, Boston Puerto Rican Health Study; GOLDN, Genetics of Lipid Lowering Drugs and Diet Network; PA, physical activity.
FIGURE 2
Predicted values of BMI by the FTO polymorphisms (recessive model) in the GOLDN study (A) and the BPRHS (B) plotted against the SFA intake (n = 881 TT+TA and n = 188 AA in GOLDN and n = 917 CC+CT and n = 177 TT in BPRHS). Predicted values were calculated from the regression models containing the SFA intake (as continuous), the FTO polymorphism, their interaction term, and the potential confounders (gender, age, smoking, drinking, PA, and total energy intake). The P value for the interaction term between SFA intake and the corresponding FTO polymorphism (rs9939609 in GOLDN and rs1121980 in BPRHS participants) was obtained in the hierarchical multivariate adjusted interaction model in which SFA intake was logarithmically transformed. BPRHS, Boston Puerto Rican Health Study; GOLDN, Genetics of Lipid Lowering Drugs and Diet Network; PA, physical activity.
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SFA intake, may reflect the high correlation between the MUFA and SFA intake (r s = 0.94; P , 0.001 for GOLDN and r s = 0.95; P , 0.001 for BPRHS) in these populations.
Discussion
We found that carriers of the minor allele (obesity risk allele) of the FTO gene did not present a greater BMI than noncarriers, either in the GOLDN study or in the BPRHS when the population was analyzed as a whole, despite the fact that many other studies have described significant associations (1) (2) (3) (4) (5) (6) (7) (8) . It has been reported that the effects of FTO variation on BMI diminish as the age of participants increases (7, 37) . Because we were studying two middle-aged populations, the FTO effects on BMI may have been of a lesser magnitude than those on children or adolescents. Age could also have another influence insofar as we did not find any association between FTO gene variation and dietary intake, because the most significant results have been found in children (26, 27, 38) and recent literature does not provide a strong support for the effect in adults (38) (39) (40) .
Moreover, we analyzed gene-environment interactions replicating previous findings and obtaining new interesting results. We first analyzed the interaction with PA, because there are numerous previous studies that reported that a greater level of PA could reduce the effects of the FTO risk allele in determining greater BMI (16) (17) (18) (19) (20) 38, 41) . We found a significant interaction between FTO gene variation and PA in determining BMI in the participants of the GOLDN study but not in participants of the BPRHS. Although the validity of the PA variable may be limited because it was self-reported in both populations, our results in the GOLDN study successfully replicated the earlier observation that a high PA level attenuates the effect of the FTO risk alleles on BMI. Several confounding factors related to the specific characteristics of the BPRHS participants (different ethnic background, greater mean age, higher prevalence of obesity, etc.) could contribute to the differences in results. However, other studies have also not been able to find any interaction between PA and the FTO polymorphisms in determining BMI in other populations (22) (23) (24) .
In contrast, we found more consistent results when we analyzed gene-diet interactions. In agreement with Sonestedt et al. (20) , who described an interaction of FTO rs9939609 with total fat and carbohydrate intake in determining BMI in Swedish men, we found some significant gene-diet interactions with dietary fat intake. Both in participants of the GOLDN study and in those of the BPRHS, the effects of the FTO risk allele increasing BMI increased with a high-fat diet. These effects were examined by using different approaches to express nutrient intake, because in gene-diet interaction studies there is a controversy over which is the best way to express nutrient contribution (whether in g/d or in percent of energy) as well as over the choice of the cutoff points to create categories of intake, given that the results may differ (36) . Having analyzed the different statistical models, the interaction with total fat intake was more significant and consistent with the results reported by Sonestedt et al. (20) in the GOLDN population than in participants of the BPRHS. One reason for these results may be that the GOLDN population is closer to the Swedish population in European genetic ancestry and age and in the amount of total fat intake than the BPRHS participants.
In addition, it is possible that some types of fatty acids had a greater effect than others in this interaction and that they were consumed more in the GOLDN population than in the BPRHS. When we studied the effect of the different types of fatty acids (SFA, MUFA, and PUFA) in greater depth, we observed stronger and more significant results on considering SFA intake. Both in participants of the GOLDN study and in those of the BPRHS, FTO polymorphisms significantly interacted with SFA intake (both as categorical and as continuous variables) in determining BMI in each population. These results suggested that high-SFA intake instead of total fat intake may be more relevant in increasing the effects of the FTO risk allele on BMI. Considering that Sonestedt et al. (20) did not examine the effect of SFA, this is the first time to our knowledge that a significant interaction between SFA intake and the FTO polymorphisms in determining BMI has been reported. Moreover, taking into account that we found this interaction in two independent populations, our results have a high level of both internal and external consistency. We obtained similar results for the interaction terms with MUFA intake due to the strong correlation that exists between MUFA and SFA consumption in North American populations. Additional studies in Mediterranean populations, where there are important differences in the sources of MUFA (mainly olive oil) and SFA (meats, milk, etc.), are required to specifically test the separate role of SFA and MUFA intake on this interaction. Nevertheless, the biological mechanisms underlying this interaction in determining BMI remain unknown and require directed molecular research.
Strengths of the present study include the analysis of interactions in two well-characterized independent populations, the use of well-validated dietary questionnaires, and the use of consistent models for statistical analysis. The main limitation derives form the cross-sectional study design.
In conclusion, our study confirms previous findings that total fat intake interacts with the FTO gene variation in determining BMI. On studying that interaction in greater depth, we found that the effects of SFA intake on modulating the association between the FTO risk-allele and higher BMI seem stronger than that of total fat. We found this interaction in two American populations, obtaining a greater level of consistency than for the interaction with PA.
